AUDREY KELLY: Open Payments
NPI 1851308522 · TOMS RIVER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,383 in 47 payments from 9 companies in 2025. Trend: 2023 $2,248 · 2024 $141 · 2025 $1,383
Food & beverage: $1,271Education: $111
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $580 |
| Teva Pharmaceuticals USA, Inc. | 6 | $170 |
| Vanda Pharmaceuticals Inc. | 5 | $163 |
| E.R. Squibb & Sons, L.L.C. | 3 | $162 |
| Alkermes, Inc. | 3 | $158 |
| ABBVIE INC. | 4 | $61 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
Products named: CAPLYTA, FANAPT, COBENFY, LYBALVI, VRAYLAR, AUSTEDO XR, REXULTI, Auvelity.
Industry payments across NJ — which companies pay providers there.
